The economics of HIV/AIDS in low-income countries: the case for prevention

J Econ Perspect. 2006 Summer;20(3):121-42. doi: 10.1257/jep.20.3.121.
No abstract available

MeSH terms

  • Acquired Immunodeficiency Syndrome* / economics
  • Acquired Immunodeficiency Syndrome* / epidemiology
  • Acquired Immunodeficiency Syndrome* / prevention & control
  • Acquired Immunodeficiency Syndrome* / transmission
  • Anti-Retroviral Agents / therapeutic use
  • Communicable Disease Control*
  • Cost of Illness*
  • Cost-Benefit Analysis
  • Developing Countries / economics
  • HIV Infections* / economics
  • HIV Infections* / epidemiology
  • HIV Infections* / prevention & control
  • HIV Infections* / therapy
  • HIV Infections* / transmission
  • Health Expenditures
  • Humans
  • Poverty
  • Prevalence
  • Public Health / economics

Substances

  • Anti-Retroviral Agents